 |
|
Cancer Studies Explore Targeted Therapy, Researchers Seek New Prevention Strategies
Joan Stephenson, PhD
JAMA. 2002;287:3063-3067.
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
Orlando, Fla—In the second labor of Hercules, the Greek hero and his nephew Iolaus found that slaying the many-headed Hydra required a multifaceted approach: Chopping off the Hydra's secondary "mortal" heads, burning the stumps to prevent new ones from growing, and burying the monster's primary "immortal" head under a rock. Cancer researchers are similarly exploring multiple strategies in their own Herculean labor: Understanding and attacking cancer in its many manifestations.
New studies reported at the annual meeting of the American Society of Clinical Oncology reveal that investigators are finding an expanded role for a recently approved drug that targets a molecular glitch in leukemia cells. Other research involves exploration of strategies for reducing the likelihood of cancer in people at high risk for such malignancies as lung, breast, and ovarian cancers.
TARGETED THERAPY
The optimism generated by the prospect of targeted therapies—agents that target specific molecular . . . [Full Text of this Article]
|
